0001638599-18-000026.txt : 20180102 0001638599-18-000026.hdr.sgml : 20180102 20180102181528 ACCESSION NUMBER: 0001638599-18-000026 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20171229 FILED AS OF DATE: 20180102 DATE AS OF CHANGE: 20180102 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Ono Richard Dana CENTRAL INDEX KEY: 0001595989 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36357 FILM NUMBER: 18502936 MAIL ADDRESS: STREET 1: 18 SPRING ROAD CITY: CONCORD STATE: MA ZIP: 01742 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Lipocine Inc. CENTRAL INDEX KEY: 0001535955 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 990370688 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 675 ARAPEEN DRIVE, SUITE 202 CITY: SALT LAKE CITY STATE: X1 ZIP: 84108 BUSINESS PHONE: 801 994 7383 MAIL ADDRESS: STREET 1: 675 ARAPEEN DRIVE, SUITE 202 CITY: SALT LAKE CITY STATE: X1 ZIP: 84108 FORMER COMPANY: FORMER CONFORMED NAME: MARATHON BAR CORP DATE OF NAME CHANGE: 20111130 4 1 doc4_5174.xml PRIMARY DOCUMENT X0306 4 2017-12-29 0 0001535955 Lipocine Inc. LPCN 0001595989 Ono Richard Dana C/O 675 ARAPEEN DRIVE SUITE 202 SALT LAKE CITY UT 84108 1 0 0 0 Common Stock 2017-12-29 4 M 0 1750 0 A 5750 D Common stock 2017-12-29 4 S 0 875 3.4667 D 4875 D Restricted Stock Unit 0 2017-12-29 4 M 0 1750 0 D 2017-12-29 2027-01-25 Common stock 1750 5250 D Represents shares of Lipocine Inc. common stock ("LPCN Common Stock") acquired upon the vesting of restricted stock units (see footnote 4). The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. Represents the weighted average price of shares sold at a price that ranged from $3.43-$3.54. Subject to vesting whereby 1/4 of the shares subject to the award will vest on December 29, 2017 and the remaining 3/4 of the shares subject to the award will vest on the receipt by the Company of FDA approval of LPCN 1021. /s/Richard Dana Ono 2018-01-02